HK1073075A1 - Use of an opuntia ficus-indica extract and compounds isolated therefrom for the preparation of the medicament for protecting nerve cells - Google Patents

Use of an opuntia ficus-indica extract and compounds isolated therefrom for the preparation of the medicament for protecting nerve cells

Info

Publication number
HK1073075A1
HK1073075A1 HK05105788A HK05105788A HK1073075A1 HK 1073075 A1 HK1073075 A1 HK 1073075A1 HK 05105788 A HK05105788 A HK 05105788A HK 05105788 A HK05105788 A HK 05105788A HK 1073075 A1 HK1073075 A1 HK 1073075A1
Authority
HK
Hong Kong
Prior art keywords
medicament
preparation
nerve cells
isolated therefrom
compounds isolated
Prior art date
Application number
HK05105788A
Other languages
English (en)
Inventor
Yong Sup Lee
Hokoon Park
Changbae Jin
Hyoung Ja Kim
Jungsook Cho
Mijeong Park
Yunseon Song
Original Assignee
Korea Inst Sci & Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Inst Sci & Tech filed Critical Korea Inst Sci & Tech
Publication of HK1073075A1 publication Critical patent/HK1073075A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
HK05105788A 2001-10-29 2005-07-11 Use of an opuntia ficus-indica extract and compounds isolated therefrom for the preparation of the medicament for protecting nerve cells HK1073075A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20010066810 2001-10-29
PCT/KR2002/002010 WO2003037324A1 (fr) 2001-10-29 2002-10-29 Utilisation d'un extrait opuntia ficus-indica et de composes isoles de celui-ci pour proteger des cellules nerveuses

Publications (1)

Publication Number Publication Date
HK1073075A1 true HK1073075A1 (en) 2005-09-23

Family

ID=36293178

Family Applications (2)

Application Number Title Priority Date Filing Date
HK05105788A HK1073075A1 (en) 2001-10-29 2005-07-11 Use of an opuntia ficus-indica extract and compounds isolated therefrom for the preparation of the medicament for protecting nerve cells
HK07102163A HK1094868A1 (en) 2001-10-29 2007-02-27 Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK07102163A HK1094868A1 (en) 2001-10-29 2007-02-27 Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells

Country Status (10)

Country Link
US (1) US7563467B2 (fr)
EP (1) EP1448188A4 (fr)
JP (1) JP4418675B2 (fr)
KR (1) KR100523562B1 (fr)
CN (2) CN100379414C (fr)
AU (1) AU2002348598B2 (fr)
CA (1) CA2465438A1 (fr)
HK (2) HK1073075A1 (fr)
NZ (1) NZ532628A (fr)
WO (1) WO2003037324A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10350194B4 (de) * 2003-10-28 2005-11-10 Bioplanta Arzneimittel Gmbh Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
JP4698167B2 (ja) * 2004-06-10 2011-06-08 株式会社ノエビア アルツハイマー病予防・治療剤
US7879374B2 (en) 2005-07-22 2011-02-01 Cellutions, LLC Composition including superoxide dismutase and prickly-pear cactus for minimizing and preventing hangovers
KR100726266B1 (ko) 2005-11-24 2007-06-08 (주) 디지탈바이오텍 플라보노이드계 화합물을 함유하는 인지기능 장애의 예방및 치료용 조성물
CN100417643C (zh) * 2006-04-29 2008-09-10 广州大学 一种从落叶松中提取二氢槲皮素的方法
WO2008038849A1 (fr) * 2006-09-29 2008-04-03 Korea Institute Of Science And Technology Composition pharmaceutique comprenant un extrait d'opuntia ficus-indica
EP2057994A1 (fr) 2007-11-06 2009-05-13 Finzelberg GmbH & Co. KG Préparation d'extrait de cactus à figues
DE102008029460A1 (de) * 2008-06-20 2009-12-31 Otkrytoe Aktsionernoe Obschestvo Zavod Ekologicheskoy Tekhniki I Ekopitaniya 'diod' Taxifolinderivate zur Prophylaxe und Behandlung von neurologischen und psychiatrischen Störungen des zentralen Nervensystems
AT507988B1 (de) * 2009-01-15 2012-06-15 Kaahee Res And Dev Gmbh Kaktusfruchtextrakt
CN101822634A (zh) * 2010-02-11 2010-09-08 匡海学 二氢槲皮素口服固体分散体制剂及其制备方法和用途
WO2012019435A2 (fr) * 2010-08-10 2012-02-16 The Hong Kong University Of Science And Technology Composition pour traiter une maladie neurodégénérative ou un état neuropathologique
WO2012138190A2 (fr) 2011-04-06 2012-10-11 한국생명공학연구원 Composition contenant des extraits de rhodotypos scandens
US11412775B2 (en) 2012-10-09 2022-08-16 R.J. Reynolds Tobacco Company Tobacco-derived composition
US9101580B2 (en) * 2012-12-18 2015-08-11 Matthew Bennett Compositions and methods for treating traumatic brain injury
JP6732004B2 (ja) * 2016-02-19 2020-07-29 国立大学法人鳥取大学 認知症治療薬または予防薬
CN107753475A (zh) * 2017-11-16 2018-03-06 黑龙江葆纳生物科技有限责任公司 山奈酚在神经细胞保护中的应用
CN108310002B (zh) * 2018-04-12 2020-07-21 广州中医药大学(广州中医药研究院) 一种预防和/或治疗血管损伤疾病的组合物及其用途
KR102205674B1 (ko) 2019-09-10 2021-01-21 고려은단주식회사 섬쑥부쟁이 추출물과 손바닥선인장 추출물의 혼합물을 포함하는 인지기능 개선용 조성물
TR201922103A2 (tr) * 2019-12-27 2020-06-22 Ankara Ueniversitesi Opuntia ficus-indica bitkisinin kladotlarından elde edilen özgün fraksiyonların kanser tedavisinde kullanılması

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860710A (en) * 1966-07-26 1975-01-14 Consiglio Nazionale Ricerche Method of inhibiting viral lysis in nonhuman flora and fauna systems
JPS6185324A (ja) 1984-10-04 1986-04-30 Satoshi Sasaki 抗癌剤の製造法
JP3978250B2 (ja) * 1996-08-16 2007-09-19 株式会社フジモト・コーポレーション テストステロン５α−リダクターゼ阻害剤
RU2090205C1 (ru) * 1996-12-02 1997-09-20 Владимир Карлович Колхир Способ комплексной терапии заболеваний
KR100543151B1 (ko) * 1997-01-16 2006-01-20 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 산화방지제와의 상승적인 상호작용을 통해 폴리시클릭 페놀계화합물의 세포 보호 효과를 증강시키는 조성물
IT1302125B1 (it) 1998-08-03 2000-07-31 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide

Also Published As

Publication number Publication date
EP1448188A1 (fr) 2004-08-25
KR20030035974A (ko) 2003-05-09
CN1823759A (zh) 2006-08-30
US7563467B2 (en) 2009-07-21
WO2003037324A1 (fr) 2003-05-08
JP2005508974A (ja) 2005-04-07
EP1448188A4 (fr) 2008-11-26
HK1094868A1 (en) 2007-04-13
KR100523562B1 (ko) 2005-10-25
US20050042311A1 (en) 2005-02-24
NZ532628A (en) 2006-02-24
JP4418675B2 (ja) 2010-02-17
CN100379414C (zh) 2008-04-09
CN1596110A (zh) 2005-03-16
AU2002348598B2 (en) 2006-12-14
CN1289079C (zh) 2006-12-13
CA2465438A1 (fr) 2003-05-08

Similar Documents

Publication Publication Date Title
HK1073075A1 (en) Use of an opuntia ficus-indica extract and compounds isolated therefrom for the preparation of the medicament for protecting nerve cells
IL156399A (en) Use of Changed Erythropoietin to Beat Drugs to Protect, Rehabilitate and Amplify Cells, Tissues and Organs Responding to Erythropoietin
IL196301A0 (en) Medicament for the treatment of hapatitis c
SI1757606T1 (sl) Ksantinski derivati za uporabo kot zdravila kot tudi postopek za njihovo pripravo
AU2002333644A1 (en) Dry powder medicament formulations
IL172695A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
HUP0401642A3 (en) Use of staurosporine derivatives for the preparation of pharmaceutical compositions
IL155071A0 (en) Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
HUP0204557A3 (en) Benzazole derivatives, their use as jnk modulators, their preparation and pharmaceutical compositions containing them
EP1153601A4 (fr) Preparation pour la peau a usage externe
HUP0200859A3 (en) Cyclo-alkyl substituted benzimidazoles, pharmaceutical compositions containing them, their preparation and their use
IL159006A0 (en) Phenoxy-phenyl derivatives and pharmaceutical compositions containing the same
AU2021601A (en) Composition for the treatment of dandruff
AU2002213174A1 (en) Treatment of apoptotic cell death
HUP0201810A3 (en) Sootepenseone and its derivatives, their preparation and use as medicament
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001252235A1 (en) A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
AU1022501A (en) Use of compositions for the caring treatment of the skin
AU1848801A (en) Formulation containing peanut leaf extract and its preparation
CA2424088A1 (fr) Preparation dermatologique
AU2683500A (en) Compositions for the treatment of pain
AU2002328568A1 (en) External preparation for the skin and copolymer to be used therein
AU2001237029A1 (en) Compositions comprising flavopiridol and their use for hiv therapy
EP1137386B8 (fr) Utilisation du triclosan comme agent anti-malaria

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141029